AGP Limited (PSX:AGP)

Pakistan · Delayed Price · Currency is PKR

156.49

-1.38 (-0.87%)

At close: Sep 29, 2026

Market Cap	43.61B -21.9%
Revenue (ttm)	27.70B +6.1%
Net Income	3.72B +7.9%
EPS	13.31 +8.1%
Shares Out	278.70M
PE Ratio	11.76
Forward PE	10.56
Dividend	8.00 (5.11%)
Ex-Dividend Date	Sep 2, 2026

Volume	33,218
Open	158.00
Previous Close	157.87
Day's Range	156.01 - 158.00
52-Week Range	150.00 - 258.67
Beta	0.47
Analysts	Buy
Price Target	246.40 (+57.45%)
Est. Earnings	Oct 23, 2026

About AGP Limited

AGP Limited operates as an independent pharmaceutical manufacturing company in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antipsychotics, biguanide and S-urea combs, and bile stone the... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1989

Employees 2,143

Stock Exchange Pakistan Stock Exchange

Ticker Symbol AGP

Full Company Profile

Financial Performance

In 2025, AGP Limited's revenue was 28.89 billion, an increase of 15.40% compared to the previous year's 25.03 billion. Earnings were 3.74 billion, an increase of 39.91%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for AGP stock is "Buy." The 12-month stock price target is Rs 246.40, which is an increase of 57.45% from the latest price.

Price Target

Rs 246.40

(57.45% upside)

Analyst Consensus: Buy

Stock Forecasts